Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record adds a recruitment-closed notice and new help sections for readers, standardizes the Intervention/Treatment heading, and updates the site revision to v3.6.0.SummaryDifference0.4%

- Check10 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a minor update rather than a change to substantive study details or primary content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3; this indicates a maintenance version update to the site and does not alter study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor update to the study record.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Hepatocellular carcinoma as the condition and the Genetic and Rare Diseases Information Center as a new resource. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.